{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:36:47Z","timestamp":1793831807142,"version":"4.6.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundamental A\/S"},{"name":"Holbaek Hospital Innovation and Development Fund"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Immune dysregulation with an excessive release of cytokines has been identified as a key driver in the development of severe COVID-19. The aim of this study was to evaluate the initial cytokine profile associated with 90-day mortality and respiratory failure in a cohort of patients hospitalized with COVID 19 that did not receive immunomodulatory therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Levels of 45 cytokines were measured in blood samples obtained at admission from patients with confirmed COVID-19. Logistic regression analysis was utilized to determine the association between cytokine levels and outcomes. The primary outcome was death within 90 days from admission and the secondary outcome was need for mechanical ventilation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 132 patients were included during the spring of 2020. We found that one anti-inflammatory cytokine, one pro-inflammatory cytokine, and five chemokines were associated with the odds of 90-day mortality, specifically: interleukin-1 receptor antagonist, interleukin-6, interleukin-8, monocyte chemoattractant protein-1, macrophage inflammatory protein-3\u03b1, macrophage inflammatory protein-3\u03b2, and fractalkine. All but fractalkine were also associated with the odds of respiratory failure during admission. Monocyte chemoattractant protein-1 showed the strongest estimate of association with both outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We showed that one anti-inflammatory cytokine, one pro-inflammatory cytokine, and five chemokines were associated with 90-day mortality in patients hospitalized with COVID-19 that did not receive immunomodulatory therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0306854","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:38:02Z","timestamp":1720633082000},"page":"e0306854","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Higher levels of IL-1ra, IL-6, IL-8, MCP-1, MIP-3\u03b1, MIP-3\u03b2, and fractalkine are associated with 90-day mortality in 132 non-immunomodulated hospitalized patients with COVID-19"],"prefix":"10.1371","volume":"19","author":[{"given":"Liv","family":"Rab\u00f8l Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-3945","authenticated-orcid":true,"given":"Bettina","family":"Hindsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bastrup Israelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-0411","authenticated-orcid":true,"given":"Pal","family":"Bela Szecsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"pone.0306854.ref001","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"W Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0306854.ref002","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"EJ Williamson","year":"2020","journal-title":"Nature"},{"key":"pone.0306854.ref003","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"D Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"pone.0306854.ref004","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"J Hadjadj","year":"2020","journal-title":"Science"},{"key":"pone.0306854.ref005","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"DC Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0306854.ref006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon\u2010\u03b3\u2010related cytokine storm in SARS patients","volume":"75","author":"K Huang","year":"2005","journal-title":"J Med Virol"},{"key":"pone.0306854.ref007","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"MD de Jong","year":"2006","journal-title":"Nat Med"},{"key":"pone.0306854.ref008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"M Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0306854.ref009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"key":"pone.0306854.ref010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"The RECOVERY Collaborative Group","year":"2021","journal-title":"N Engl J Med"},{"key":"pone.0306854.ref011","article-title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19","year":"2021","journal-title":"N Engl J Med"},{"key":"pone.0306854.ref012","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","article-title":"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"pone.0306854.ref013","doi-asserted-by":"crossref","first-page":"2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From Clinical Significance to Quantification","volume":"8","author":"C Liu","year":"2021","journal-title":"Advanced Science"},{"key":"pone.0306854.ref014","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The Many Roles of Chemokines and Chemokine Receptors in Inflammation","volume":"354","author":"IF Charo","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"pone.0306854.ref015","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"T Chen","year":"2020","journal-title":"BMJ"},{"key":"pone.0306854.ref016","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"DM Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"pone.0306854.ref017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12016-021-08908-8","article-title":"Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis","volume":"64","author":"R Qin","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"pone.0306854.ref018","unstructured":"Danish Covid-19 Genome Consortium. [cited 9 May 2024]. Available: https:\/\/covid19genomics.dk\/home"},{"key":"pone.0306854.ref019","article-title":"Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020","author":"SB Israelsen","year":"2020","journal-title":"Danish Medical Journal"},{"key":"pone.0306854.ref020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","article-title":"Clinical determinants for fatality of 44,672 patients with COVID-19","volume":"24","author":"G Deng","year":"2020","journal-title":"Crit Care"},{"key":"pone.0306854.ref021","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2013"},{"key":"pone.0306854.ref022","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"T Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0306854.ref023","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/jmv.26589","article-title":"Evaluation of alpha defensin, IL\u20101 receptor antagonist, and IL\u201018 levels in COVID\u201019 patients with macrophage activation syndrome and acute respiratory distress syndrome","volume":"93","author":"B Kerget","year":"2021","journal-title":"J Med Virol"},{"key":"pone.0306854.ref024","doi-asserted-by":"crossref","first-page":"eabe3024","DOI":"10.1126\/sciadv.abe3024","article-title":"Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm","volume":"6","author":"PA Mudd","year":"2020","journal-title":"Sci Adv"},{"key":"pone.0306854.ref025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the Inflammatory Response to Severe COVID-19 Illness","volume":"202","author":"OJ McElvaney","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0306854.ref026","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"E Kyriazopoulou","year":"2021","journal-title":"Nat Med"},{"key":"pone.0306854.ref027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-2600(20)30556-7","article-title":"Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial","volume":"9","year":"2021","journal-title":"Lancet Respir Med"},{"key":"pone.0306854.ref028","doi-asserted-by":"crossref","first-page":"e144455","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"MS Abers","journal-title":"JCI Insight"},{"key":"pone.0306854.ref029","doi-asserted-by":"crossref","first-page":"21697","DOI":"10.1038\/s41598-020-78710-7","article-title":"Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19","volume":"10","author":"M J\u00f8ntvedt J\u00f8rgensen","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0306854.ref030","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1164\/rccm.202005-1885OC","article-title":"Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome","volume":"202","author":"S Hue","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0306854.ref031","doi-asserted-by":"crossref","first-page":"103672","DOI":"10.1016\/j.isci.2021.103672","article-title":"Integrated miRNA\/cytokine\/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19","volume":"25","author":"JC Wilson","year":"2021","journal-title":"iScience"},{"key":"pone.0306854.ref032","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/thorax-2023-219989","article-title":"Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality","volume":"78","author":"J de Brabander","year":"2023","journal-title":"Thorax"},{"key":"pone.0306854.ref033","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1093\/infdis\/jiac313","article-title":"High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19","volume":"226","author":"A Tveita","year":"2022","journal-title":"J Infect Dis"},{"key":"pone.0306854.ref034","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cell.2022.01.012","article-title":"A blood atlas of COVID-19 defines hallmarks of disease severity and specificity","volume":"185","author":"DJ Ahern","year":"2022","journal-title":"Cell"},{"key":"pone.0306854.ref035","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.3390\/ijms231810344","article-title":"Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients","volume":"23","author":"J Monserrat","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0306854.ref036","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/infdis\/jiaa349","article-title":"Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients","volume":"222","author":"M Tong","year":"2020","journal-title":"J Infect Dis"},{"key":"pone.0306854.ref037","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"C Huang","year":"2020","journal-title":"Lancet"},{"key":"pone.0306854.ref038","doi-asserted-by":"crossref","first-page":"1170012","DOI":"10.3389\/fimmu.2023.1170012","article-title":"Characterisation of the pro-inflammatory cytokine signature in severe COVID-19","volume":"14","author":"HC Hawerkamp","year":"2023","journal-title":"Front Immunol"},{"key":"pone.0306854.ref039","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jama.2023.11043","article-title":"Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial","volume":"330","author":"JA O\u2019Halloran","year":"2023","journal-title":"JAMA"},{"key":"pone.0306854.ref040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","article-title":"Efficacy of CytoSorb\u00ae: a systematic review and meta-analysis","volume":"27","author":"S Becker","year":"2023","journal-title":"Crit Care"},{"key":"pone.0306854.ref041","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/SHK.0000000000002189","article-title":"EFFICACY OF SUPPLEMENTAL HEMOADSORPTION THERAPY ON SEVERE AND CRITICAL PATIENTS WITH COVID-19: AN EVIDENCE-BASED ANALYSIS","volume":"60","author":"J He","year":"2023","journal-title":"Shock"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0306854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:38:28Z","timestamp":1720633108000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0306854"}},"subtitle":[],"editor":[{"given":"Mar\u00eda","family":"Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0306854","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}